Targeted Therapies in Metastatic RCC Monotherapy versus Combination Therapy

Targeted Therapies in Metastatic RCC Monotherapy versus Combination Therapy

0% Complete

Course Overview

NA

Course Content

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Objectives

NA

Target Audience

NA

Faculty & Disclosure

Faculty

Primo N. Lara, Jr., MD

Disclosure

Primo N. Lara, Jr., MD discloses no such relationships exist

Accreditation

NA